RNGCX
Price
$64.05
Change
+$0.63 (+0.99%)
Updated
Jun 26 closing price
Net Assets
38.27B
RNPGX
Price
$69.23
Change
+$0.63 (+0.92%)
Updated
Jun 26 closing price
Net Assets
152.59B
Interact to see
Advertisement

RNGCX vs RNPGX

Header iconRNGCX vs RNPGX Comparison
Open Charts RNGCX vs RNPGXBanner chart's image
American Funds New Economy R3
Price$64.05
Change+$0.63 (+0.99%)
VolumeN/A
Net Assets38.27B
American Funds New Perspective R6
Price$69.23
Change+$0.63 (+0.92%)
VolumeN/A
Net Assets152.59B
RNGCX vs RNPGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RNGCX vs. RNPGX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNGCX is a Buy and RNPGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 153B vs. RNGCX (38.3B). RNPGX pays higher dividends than RNGCX: RNPGX (0.82) vs RNGCX (0.00). RNGCX was incepted earlier than RNPGX: RNGCX (23 years) vs RNPGX (16 years). RNGCX (1.06) is less costly to investors than RNPGX (0.41). RNGCX is a more actively managed with annual turnover of: 36.00 vs. RNPGX (24.00). RNGCX (250) and RNPGX (250) have matching initial minimum investment requirements. RNPGX annual gain was more profitable for investors over the last year : 11.34 vs. RNGCX (6.24). RNPGX return over 5 years is better than : 51.75 vs. RNGCX (40.28).
RNGCXRNPGXRNGCX / RNPGX
Total Expense Ratio1.060.41259%
Annual Report Gross Expense Ratio1.060.41259%
Fund Existence23 years16 years-
Gain YTD9.90011.39287%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets38.3B153B25%
Annual Yield % from dividends0.000.82-
Returns for 1 year6.2411.3455%
Returns for 3 years50.5641.35122%
Returns for 5 years40.2851.7578%
Returns for 10 years64.8285.8176%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBY0.600.03
+4.60%
NovaBay Pharmaceuticals
DEI15.090.49
+3.36%
Douglas Emmett
TRST33.080.80
+2.48%
TrustCo Bank Corp
DOX91.370.71
+0.78%
Amdocs Limited
CTNM4.01-0.58
-12.64%
Contineum Therapeutics